Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026)

Amarin Corp Plcuk (AMRN) reported Change in Inventory of -$12.3 million for Q1 2026, up 11.29% year-over-year from -$11.1 million in Q1 2025, and down 686.63% quarter-over-quarter from $2.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 15 years of Change in Inventory data on file, last reported at -$12.3 million in Q1 2026.

  • Change in Inventory for Q1 2026 came in at -$12.3 million, up 11.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.3 million (up 70.42% YoY), and the FY2025 annual result was -$34.9 million, up 66.92% from the prior year.
  • Change in Inventory fell to -$12.3 million in Q1 2026 per AMRN's latest filing, from $2.1 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $52.9 million in Q1 2022 and troughed at -$67.2 million in Q4 2024.
  • A 5-year average of -$10.1 million and a median of -$12.7 million in 2024 frame the typical range for Change in Inventory.
  • The sharpest annual moves came in 2024 and 2025: Change in Inventory plunged 570.87% in 2024, then surged 103.12% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$23.2 million in 2022, then jumped by 56.84% to -$10.0 million in 2023, then sank by 570.87% to -$67.2 million in 2024, then jumped by 103.12% to $2.1 million in 2025, then tumbled by 686.63% to -$12.3 million in 2026.
  • Business Quant data shows AMRN's Change in Inventory at -$12.3 million in Q1 2026, $2.1 million in Q4 2025, and -$17.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 431.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 184.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -18.00 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 52.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -14.00 Mn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn -12.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.33 Mn
Mar 31, 2026 -12.33 Mn
Dec 31, 2025 2.10 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 -17.02 Mn
Sep 30, 2025 -17.02 Mn
Jun 30, 2025 -6.06 Mn
Jun 30, 2025 -6.06 Mn
Mar 31, 2025 -13.89 Mn
Mar 31, 2025 -13.89 Mn
Dec 31, 2024 -67.24 Mn
Dec 31, 2024 -67.24 Mn
Sep 30, 2024 -12.68 Mn
Sep 30, 2024 -12.68 Mn
Jun 30, 2024 -18.80 Mn
Jun 30, 2024 -18.80 Mn
Mar 31, 2024 -6.73 Mn
Mar 31, 2024 -6.73 Mn
Dec 31, 2023 -10.02 Mn
Dec 31, 2023 -10.02 Mn